First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension

Abstract

In our patient group, a combination of oral bosentan and sildenafil proved to be safe and effective. Clearly, randomized, double-blind, placebo-controlled studies are warranted to define the role and type of combination therapies in PAH.